Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$27.46 - $31.33 $323,973 - $369,631
11,798 New
11,798 $358,000
Q2 2023

Aug 07, 2023

BUY
$29.6 - $36.56 $769 - $950
26 Added 0.27%
9,572 $294,000
Q1 2023

May 03, 2023

BUY
$32.77 - $39.4 $48,008 - $57,721
1,465 Added 18.13%
9,546 $343,000
Q4 2022

Feb 13, 2023

BUY
$39.17 - $44.04 $88,328 - $99,310
2,255 Added 38.71%
8,081 $319,000
Q2 2022

Jan 11, 2023

SELL
$37.53 - $44.22 $12,422 - $14,636
-331 Reduced 5.38%
5,826 $245,000
Q1 2022

Jan 11, 2023

BUY
$37.46 - $42.44 $230,641 - $261,303
6,157 New
6,157 $240,000

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $10.6B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Asb Consultores, LLC Portfolio

Follow Asb Consultores, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Asb Consultores, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Asb Consultores, LLC with notifications on news.